Wuyi Sun
Key Laboratory Of Anti Inflammatory And Immune Medicine
Hefei, 230032, China
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Noncovalent and precise loading of small molecule drugs on DNA nanocarriers.
Journal: Nanoscale horizons
Published: November 26, 2025
Tryptase-like proteases: A novel perspective for fibrosis.
Journal: Life sciences
Published: June 05, 2025
Sirtuin 3, a pivotal actor in liver diseases: research progress and implications.
Journal: International journal of biological macromolecules
Published: April 23, 2025
Deficiency of β-arrestin2 ameliorates MASLD in mice by promoting the activation of TAK1/AMPK signaling.
Journal: Archives of pharmacal research
Published: November 18, 2024
β-arrestin2: an emerging player and potential therapeutic target in inflammatory immune diseases.
Journal: Acta pharmacologica Sinica
Published: May 07, 2024
Angiotensin II type-2 receptor attenuates liver fibrosis progression by suppressing IRE1α-XBP1 pathway.
Journal: Cellular signalling
Published: August 03, 2023
Dextran sulfate sodium-induced gut microbiota dysbiosis aggravates liver injury in mice with S100-induced autoimmune hepatitis.
Journal: Immunology letters
Published: April 25, 2023
Loureirin B protects against cerebral ischemia/reperfusion injury through modulating M1/M2 microglial polarization via STAT6 / NF-kappaB signaling pathway.
Journal: European journal of pharmacology
Published: January 12, 2023
β-arrestin2 deficiency ameliorates S-100-induced autoimmune hepatitis in mice by inhibiting infiltration of monocyte-derived macrophage and attenuating hepatocyte apoptosis.
Journal: Acta pharmacologica Sinica
Published: November 01, 2022
Research progress of metformin in the treatment of liver fibrosis.
Journal: International immunopharmacology
Published: October 29, 2022
A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 26, 2022
Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma.
Journal: Cancer cell international
Published: August 03, 2021
Last Updated: 09/26/2026